申请人:Linz Klaus
公开号:US20120029006A1
公开(公告)日:2012-02-02
Cis-tetrahydro-spiro(cyclohexane-1,1′-pyrido[3,4-b]indole)-4-amine compounds which act on the nociceptin/ORL-1 receptor system as well as on the μ-opioid receptor system and which are distinguished in particular by selective effectiveness in the treatment of chronic pain, such as inflammatory pain, visceral pain, tumour pain, and neuropathic pain, without at the same time developing pronounced effectiveness against acute, nociceptive pain.
Cis-四氢噻吡啶并[环己烷-1,1′-吡啶并[3,4-b]吲哚]-4-胺化合物作用于痛觉素/ORL-1受体系统以及μ-阿片受体系统,特别以其在治疗慢性疼痛(如炎症性疼痛、内脏疼痛、肿瘤疼痛和神经病理性疼痛)方面的选择性有效性而著称,同时不会对急性、痛觉性疼痛表现出显著的有效性。